Clover Health Investments (CLOV) Stock Price, Quote, News & History | Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD84,628.32+0.15%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

Clover Health Investments Corp (CLOV) Stock Price, Quote, News & History

CLOVNASDAQ

Trade with Public

Trade with Public

$4.38

0.153.55%

Last update: Oct 2, 7:27 PM

$4.36

0.133.09%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$4.27

Close

$4.38

Volume / Avg.

3.86M / 4.43M

Day Range

$4.22 - $4.41

52 Wk Range

1.58 - 5.59

Market Cap

$2.32B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

5.58%

Days to Cover

5.18

Recent Clover Health Investments, Corp. News

Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday

U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.

Avi Kapoor

Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday

US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporting strong Q2 results & raised guidance.

Avi Kapoor

Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit

Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 million in 2027 bonus payments.

Vandana Singh

Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO

Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to get in the crosshairs anymore."

Avi Kapoor

Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating

Clover Health shares are extending Wednesday's 18.9% surge after a court-ordered Medicare upgrade lifted its PPO plan to 4.5 Stars.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

77.03M

Investing Cash Flow (TTM)

-45.52M

Financing Cash Flow (TTM)

-21.33M

Free Cash Flow (TTM)

74.21M

Capital Expenditure (TTM)

-2.83M

Net Change in Cash (TTM)

10.19M

Analyst Trends and Forecast

1

1

Jun

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.00B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.90

PB Ratio (TTM)

5.98

Earnings Yield % (TTM)

-1.18%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

30.11

Book Value / Share

$0.71

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$198.84M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-